Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Fluorodeoxyglucose (FDG) positron emission tomography (PET)
RADIATION
2 trials
Sponsors
University of California, Davis
, Samus Therapeutics, Inc.
Conditions
Alzheimer Disease
Non-alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic Steatohepatitis (NASH)
Phase 2
To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
Terminated
NCT04311515
Samus Therapeutics, Inc.
Alzheimer Disease
Start: 2020-06-30
End: 2022-11-15
Updated: 2022-11-17
Unknown Phase
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
Active, not recruiting
NCT02754037
University of California, Davis
Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH)
Start: 2016-04-30
End: 2026-06-30
Target: 120
Updated: 2025-12-05
Related Papers
Non-Alcoholic Steatohepatitis Severity Associates with FGF21 Level and Kidney Glucose Uptake
Metabolic Syndrome and Related Disorders
2021-08-27
5 citations
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
Nature Communications
2021-08-03
32 citations